328 results
8-K
EX-99.1
INSM
Insmed Incorporated
4 Jun 24
Regulation FD Disclosure
7:00am
is reliable, such research has not been verified by any independent source. Please be aware that brensocatib and TPIP are investigational products that have
8-K
EX-1.1
INSM
Insmed Incorporated
30 May 24
Insmed Announces Proposed $500 Million Public Offering of Common Stock
5:32pm
of the Company, its subsidiaries, or any of their respective officers, directors, or employees, or to the knowledge of the Company, any independent … periodically conducts screening of officers, directors, employees and independent contractors to confirm such persons are not excluded, suspended
8-K
EX-5.1
INSM
Insmed Incorporated
30 May 24
Insmed Announces Proposed $500 Million Public Offering of Common Stock
5:32pm
with management and upon certificates of public officials. Except as otherwise expressly indicated, we have not undertaken any independent
424B5
aeekxzpn8 e56hyb
30 May 24
Prospectus supplement for primary offering
4:02pm
424B5
l635j ptbb3ggjq
28 May 24
Prospectus supplement for primary offering
7:14pm
S-8
EX-23.2
ayxv4nl7z8m6it3
14 May 24
Registration of securities for employees
4:06pm
S-8
EX-5.1
u9axjplzdmdi1ew9n
14 May 24
Registration of securities for employees
4:06pm
S-8
uez5z1jff
14 May 24
Registration of securities for employees
4:06pm
8-K
pq5al7qutenz
13 May 24
Departure of Directors or Certain Officers
4:18pm
8-K
EX-5.1
p9t79
22 Feb 24
Insmed Reports Fourth-Quarter and Full-Year 2023 Financial Results and Provides Business Update
7:58am
8-K
EX-10.1
de81yvmk6btpw0kr4f4
22 Feb 24
Insmed Reports Fourth-Quarter and Full-Year 2023 Financial Results and Provides Business Update
7:58am
424B5
ufaolw05cxtbzgmyom
22 Feb 24
Prospectus supplement for primary offering
7:43am
8-K
EX-99.2
5hrd cicxa8
5 Sep 23
Regulation FD Disclosure
7:00am